icd 9 code for ca125

by Ova Parisian 5 min read

795.82

Is CA125 a reliable indicator?

2012 ICD-9-CM Diagnosis Code 795.82 Elevated cancer antigen 125 [CA 125] Short description: Elev ca antigen 125. ICD-9-CM 795.82 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 795.82 should only be used for claims with a date of service on or before September 30, 2015.

What is the diagnosis code for CA 125?

Elevated cancer antigen 125 [ca 125] Short description: Elev ca antigen 125. ICD-9-CM 795.82 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 795.82 should only be used for claims with a …

What is the CPT code for CA125?

This code was replaced on September 30, 2015 by its ICD-10 equivalent. ICD-9: 795.82. Short Description: Elev ca antigen 125. Long Description: Elevated cancer antigen 125 [CA 125]

What is the CPT code for CA 125?

Jan 01, 2006 · Original Consideration for Tumor Antigen by Immunoassay CA 125 (Modification of Code List to Include ICD-9-CM Codes for Suspicious Ovarian Mass) (CAG-00284N) Additional Information Other Versions

image

What ICD 10 code will cover CA 125?

R97.1
Elevated cancer antigen 125 [CA 125]

R97. 1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.

What is immunoassay tumor CA 125?

CA 125 is a high molecular weight serum tumor marker elevated in 80% of patients who present with epithelial ovarian carcinoma. It is also elevated in carcinomas of the fallopian tube, endometrium, and endocervix.

What is the ICD 9 code for CBC and CMP?

2013 ICD-9-CM Diagnosis Code 790.99 : Other nonspecific findings on examination of blood.

What is the ICD 9 code for CBC?

2012 ICD-9-CM Diagnosis Code 790.99 : Other nonspecific findings on examination of blood.

What cancers can CA 125 detect?

Cancer antigen 125 (CA125) is a protein found on most ovarian cancer cells that is secreted into the blood stream and can be measured.
...
The CA125 blood levels can be increased in ovarian cancer and other cancers including:
  • uterine.
  • fallopian tube.
  • pancreatic.
  • breast.
  • colorectal.
  • lung.
  • stomach.

Is CA 125 covered by Medicare?

Medicare currently covers the use CA-125 for monitoring of response to therapy related to ovarian cancer.

What is R79 89?

Other specified abnormal findings of blood chemistry

R79. 89 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.

What diagnosis covers CBC?

Specific indications for CBC with differential count related to the WBC include signs, symptoms, test results, illness, or disease associated with leukemia, infections or inflammatory processes, suspected bone marrow failure or bone marrow infiltrate, suspected myeloproliferative, myelodysplastic or lymphoproliferative ...

What diagnosis code covers CMP?

Encounter for screening for other metabolic disorders

The 2022 edition of ICD-10-CM Z13. 228 became effective on October 1, 2021.

What is an ICD-9 diagnosis?

ICD-9-CM is the official system of assigning codes to diagnoses and procedures associated with hospital utilization in the United States. The ICD-9 was used to code and classify mortality data from death certificates until 1999, when use of ICD-10 for mortality coding started.

What does ICD-9 stand for?

International Classification of Diseases,Ninth Revision
International Classification of Diseases,Ninth Revision (ICD-9) Related Pages. The International Classification of Diseases (ICD) is designed to promote international comparability in the collection, processing, classification, and presentation of mortality statistics.

What is an example of an ICD-9 code?

Most ICD-9 codes are three digits to the left of a decimal point and one or two digits to the right of one. For example: 250.0 is diabetes with no complications. 530.81 is gastroesophageal reflux disease (GERD).Jan 9, 2022

Description Information

Please Note: This may not be an exhaustive list of all applicable Medicare benefit categories for this item or service.

National Coverage Analyses (NCAs)

This NCD has been or is currently being reviewed under the National Coverage Determination process. The following are existing associations with NCAs, from the National Coverage Analyses database.

Decision Summary

The Centers for Medicare and Medicaid Services (CMS) has determined that there is sufficient evidence to conclude that CA-125 testing is reasonable and necessary for the surveillance of Primary Peritoneal Carcinoma (PPC) in Medicare beneficiaries following treatment. We will add PPC to the indications described in the narrative NCD for tumor antigen by immunoassay CA-125.

Decision Memo

The Centers for Medicare and Medicaid Services (CMS) has determined that there is sufficient evidence to conclude that CA-125 testing is reasonable and necessary for the surveillance of Primary Peritoneal Carcinoma (PPC) in Medicare beneficiaries following treatment.

Bibliography

Eltabbakh GH, Piver MS, Natarajan N, Mettlin CJ. Epidemiologic differences between women with extraovarian primary peritoneal carcinoma and women with epithelial ovarian cancer. Obstetrics & Gynecology 1998;91:254-259.

image